EUVIMEDOpdag EUVIMED
Crossref

Blue‐Purple evaluation: Chromoproteins facilitate the identification of BioBrick compatibility

Fang Ba iD, Yufei Zhang, Luyao Wang, Wan-Qiu Liu, Jian Li iD

Biotechnology and Bioengineering · 2025-01 · 122 (1) · 233-241

DOI: 10.1002/bit.28862 ↗

At a glance

Journal article in Biotechnology and Bioengineering, published online on 2024-10-14. Written by Fang Ba and 4 co-authors. Institution: School of Physical Science and Technology, ShanghaiTech University, Shanghai, China. Major MEDLINE topics: Escherichia coli, Synthetic Biology. Cited 2 times so far (Crossref); 26 references. Funded by: National Key Research and Development Program of China 2023YFA0914000, National Natural Science Foundation of China 32171427, National Natural Science Foundation of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Synthetic BioBricks introduce novel capabilities to manipulate genetic information, direct transcription‐translation processes, and program cellular behaviors in living organisms. To maintain the stability and functionality of synthetic BioBricks, assembled DNA fragments should be mutually compatible without inducing negative effects such as metabolic burden or cellular toxicity in host cells. However, a simple, rapid, and reliable method to evaluate BioBrick compatibility remains to be developed. In this study, we report BP (Blue/Purple, Ban/Pick) evaluation, a method utilizing chromoproteins to facilitate the identification of BioBrick compatibility in one‐pot reactions. By visualizing and quantifying the ratio of blue to purple Escherichia coli ( E. coli ) colonies on LB‐agar plates, we can easily validate the compatibility of desired BioBrick constructions. To demonstrate our design, we characterized BioBrick assemblies with antitoxin‐toxin pair ccdA‐ccdB, lysis protein E, or heterologous protein sfGFP. Among these, we successfully identified several compatible assemblies. We anticipate that BP evaluation will enhance biotechnological assessments of BioBrick compatibility in vivo and expand the application of chromoproteins in synthetic biology.

Subjects

MeSH terms (MEDLINE)

Escherichia coliSynthetic Biology

Author keywords

BioBrick compatibilityDNA assemblybiotechnologychromoproteinmolecular cloningsynthetic biology

Authors and institutions

  • School of Physical Science and Technology, ShanghaiTech University, Shanghai, China.
  • State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University, Shanghai, China.
  • Shanghai Clinical Research and Trial Center, Shanghai, China.

ORCID profiles: Fang Ba, Jian Li

Funding

  • National Key Research and Development Program of China 2023YFA0914000
  • National Natural Science Foundation of China 32171427
  • National Natural Science Foundation of China

Cite

APA

Ba, F., Zhang, Y., Wang, L., Liu, W. Q., & Li, J. (2025). Blue‐Purple evaluation: Chromoproteins facilitate the identification of BioBrick compatibility. Biotechnology and Bioengineering, 122(1), 233-241. https://doi.org/10.1002/bit.28862

Vancouver

Ba F, Zhang Y, Wang L, Liu WQ, Li J. Blue‐Purple evaluation: Chromoproteins facilitate the identification of BioBrick compatibility. Biotechnology and Bioengineering. 2025;122(1):233-241. doi:10.1002/bit.28862

BibTeX
@article{Ba2025,
  author = {Ba, Fang and Zhang, Yufei and Wang, Luyao and Liu, Wan-Qiu and Li, Jian},
  title = {Blue‐Purple evaluation: Chromoproteins facilitate the identification of BioBrick compatibility},
  journal = {Biotechnology and Bioengineering},
  year = {2025},
  volume = {122},
  number = {1},
  pages = {233--241},
  doi = {10.1002/bit.28862}
}
Start for free →